M62812 is a drug which acts as a potent and selective antagonist of toll-like receptor 4 (TLR4).
In animal studies it blocks TLR4-mediated cytokine release and has antiinflammatory effects, showing efficacy in animal models of arthritis and septic shock.
[1][2]
This pharmacology-related article is a stub.
You can help Wikipedia by expanding it.